Miller Fisher Syndrome Presenting After a Second Dose of Pfizer-BioNTech Vaccination in a Patient With Resolved COVID-19: A Case Report.

Michaelson, Nara Miriam; Lam, Tiffany; Malhotra, Ashwin; Schiff, Nicholas D; MacGowan, Daniel James Lysaght

Michaelson, Nara Miriam; Lam, Tiffany; Malhotra, Ashwin; Schiff, Nicholas D; MacGowan, Daniel James Lysaght.

Michaelson NM; Department of Neurology, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY.
Lam T; Weill Cornell Graduate School of Medical Sciences, New York, NY.
Malhotra A; Department of Neurology, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY.
Schiff ND; Department of Neurology, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY.
MacGowan DJL; Department of Neurology, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY.

J Clin Neuromuscul Dis ; 23(2): 113-115, 2021 Dec 01.

Article in English | MEDLINE | ID: covidwho-1528205

Subject(s)

BNT162 Vaccine/adverse effects; COVID-19; Miller Fisher Syndrome; Adverse Drug Reaction Reporting Systems; Aged; BNT162 Vaccine/administration & dosage; COVID-19/prevention & control; COVID-19/therapy; Humans; Male; Miller Fisher Syndrome/diagnosis; Miller Fisher Syndrome/drug therapy; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Miller Fisher Syndrome / COVID-19 / BNT162 Vaccine Type of study: Case report / Diagnostic study / Observational study Topics: Vaccines / Variants Limits: Aged / Humans / Male Language: English Journal: J Clin Neuromuscul Dis Journal subject: Physiology / Neurology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google